ID2 and hepatocellular carcinoma: This results in epigenetic modification and activation of the enhancer and modulation of ID2 expression which, in turn, regulates Epithelial-Mesenchymal Transition (EMT) progression to suppress HCC metastasis (Zhou et al., 2020).